drug
KT-621
Phase 2updated 5mo agoby $KYMR Kymera Therapeutics, Inc.
Phase 2community read0 votes
indications
indications
Asthma
all catalysts(0)
nothing on the calendar yet
Trials studying KT-621
- phase2A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
- phase2A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- phase1Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
- phase1First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
News(1)
- 6 immunology targets to sustain a mammoth I&I marketJohnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and…biospace · 6d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that